拉夏貝爾(06116.HK)提前收回出售黯涉電子商務股份剩餘代價
格隆匯2月2日丨拉夏貝爾(06116.HK)公佈,就出售黯涉電子商務股份事項,截至2021年1月29日,公司已配合買方解除了股權質押及商標質押的質押登記,並收到買方支付的人民幣6500萬元,作為經調整的代價的一部分,買方亦同時代公司向杭州煦旭支付了經調整的代價的剩餘部分人民幣1600萬元款項,經雙方確認出售事項的代價已全部支付完畢,出售事項全部完成。
本次提前收回剩餘代價並相應調整部分剩餘代價是基於公司現階段實際情況決定的。公司認為,提前收回剩餘代價有利於緩解公司現金流壓力,為主營業務發展提供資金支援,有利於保障公司正常生產經營活動,進一步增強公司持續經營能力,符合公司現階段實際情況及全體股東利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.